Drägerwerk AG & Co. KGaA (LON:0MT8)
London · Delayed Price · Currency is GBP · Price in EUR 69.60
0.00 (0.00%)
Feb 12, 2026, 1:12 PM GMT
Drägerwerk AG & Co. KGaA Market Cap
Drägerwerk AG & Co. KGaA has a market cap or net worth of 1.26 billion as of February 12, 2026. Its market cap has increased by 56.58% in one year.
Market Cap
1.26B
Enterprise Value
1.43B
Revenue
2.98B
Ranking
n/a
PE Ratio
11.99
Stock Price
69.60
Market Cap Chart
Since December 31, 1996, Drägerwerk AG & Co. KGaA's market cap has increased from 98.80M to 1.26B, an increase of 1,180.14%. That is a compound annual growth rate of 9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.26B | 23.83% |
| Dec 30, 2025 | 1.02B | 50.51% |
| Dec 30, 2024 | 678.65M | -13.07% |
| Dec 29, 2023 | 780.68M | 21.68% |
| Dec 30, 2022 | 641.57M | -25.01% |
| Dec 30, 2021 | 855.57M | -17.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.29B |
| Oxford Biomedica | 986.00M |